Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized ropivacaine with or without dexamethasone for postoperative sore throat after double-lumen bronchial intubation
ChiCTR2400079599Phase 2Not yet recruiting
- Sponsor
- First Affiliated Hospital of Gannan Medical University
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ropivacaine and dexamethasone in Post-extubation sore throat (POST) (3 arms), sponsored by First Affiliated Hospital of Gannan Medical University. Primary endpoints: Incidence of sore throat at rest, Visual analog score of sore throat at rest and 4 more. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
ropivacainedexamethasone
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on ChiCTR2400079599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079599.